These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 15184636

  • 1. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
    Ohta K, Shigemoto K, Kubo S, Maruyama N, Abe Y, Ueda N, Ohta M.
    Neurology; 2004 Jun 08; 62(11):2132-3. PubMed ID: 15184636
    [No Abstract] [Full Text] [Related]

  • 2. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.
    Jordan B, Schilling S, Zierz S.
    J Neurol; 2016 Jan 08; 263(1):174-6. PubMed ID: 26645394
    [No Abstract] [Full Text] [Related]

  • 3. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A, Djukic P, Basta I, Hajdukovic Lj, Stojanovic VR, Stevic Z, Nikolic D, Bozic V, Lavrnic S, Lavrnic D.
    Clin Neurol Neurosurg; 2013 Apr 08; 115(4):432-7. PubMed ID: 22770539
    [Abstract] [Full Text] [Related]

  • 4. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
    Nakata R, Motomura M, Masuda T, Shiraishi H, Tokuda M, Fukuda T, Ando T, Yoshimura T, Tsujihata M, Kawakami A.
    Eur J Neurol; 2013 Sep 08; 20(9):1272-6. PubMed ID: 23679930
    [Abstract] [Full Text] [Related]

  • 5. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.
    Zhang DQ, Wang R, Li T, Li X, Qi Y, Wang J, Yang L.
    J Neuroimmunol; 2015 Jun 15; 283():7-10. PubMed ID: 26004149
    [Abstract] [Full Text] [Related]

  • 6. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
    Kuks JB, Oosterhuis HJ, Limburg PC, The TH.
    J Autoimmun; 1991 Apr 15; 4(2):197-211. PubMed ID: 1883480
    [Abstract] [Full Text] [Related]

  • 7. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.
    Takamori M, Motomura M, Kawaguchi N, Nemoto Y, Hattori T, Yoshikawa H, Otsuka K.
    Neurology; 2004 May 25; 62(10):1894-6. PubMed ID: 15159506
    [Abstract] [Full Text] [Related]

  • 8. Is "seronegative" MG explained by autoantibodies to MuSK?
    Vincent AC, McConville J, Newsom-Davis J.
    Neurology; 2005 Jan 25; 64(2):399; author reply 399. PubMed ID: 15668461
    [No Abstract] [Full Text] [Related]

  • 9. [Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].
    Ito T, Ishizumi T, Kataba H, Saijo T, Ikeda N.
    Kyobu Geka; 2018 Aug 25; 71(8):634-636. PubMed ID: 30185764
    [Abstract] [Full Text] [Related]

  • 10. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.
    Yang L, Maxwell S, Leite MI, Waters P, Clover L, Fan X, Zhang D, Yang C, Beeson D, Vincent A.
    J Neurol Sci; 2011 Feb 15; 301(1-2):71-6. PubMed ID: 21131008
    [Abstract] [Full Text] [Related]

  • 11. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L, Andreetta F, Antozzi C, Confalonieri P, Cornelio F, Scaioli V, Mantegazza R.
    Neuromuscul Disord; 2008 Aug 15; 18(8):678-80. PubMed ID: 18657424
    [Abstract] [Full Text] [Related]

  • 12. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
    Baggi F, Andreetta F, Antozzi C, Simoncini O, Confalonieri P, Labeit S, Cornelio F, Mantegazza R.
    Ann N Y Acad Sci; 1998 May 13; 841():538-41. PubMed ID: 9668290
    [No Abstract] [Full Text] [Related]

  • 13. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L, Ranelletti F, Maggiano N, Guerriero M, Punzi C, Marsili F, Bartoccioni E, Evoli A.
    Neurology; 2005 Feb 08; 64(3):536-8. PubMed ID: 15699390
    [Abstract] [Full Text] [Related]

  • 14. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
    Skeie GO, Romi F.
    Eur J Neurol; 2008 Oct 08; 15(10):1029-33. PubMed ID: 18717725
    [Abstract] [Full Text] [Related]

  • 15. Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy.
    Wolfe GI, Kaminski HJ, Jaretzki A, Swan A, Newsom-Davis J.
    Ann N Y Acad Sci; 2003 Sep 08; 998():473-80. PubMed ID: 14592916
    [Abstract] [Full Text] [Related]

  • 16. MuSK-positive myasthenia gravis is rare in the Polish population.
    Kostera-Pruszczyk A, Kamińska A, Dutkiewicz M, Emeryk-Szajewska B, Strugalska-Cynowska MH, Vincent A, Kwieciński H.
    Eur J Neurol; 2008 Jul 08; 15(7):720-4. PubMed ID: 18494794
    [Abstract] [Full Text] [Related]

  • 17. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A, Lauria G, Piamarta F, Fiumani A, Agostoni E.
    J Neurol Sci; 2011 Mar 15; 302(1-2):112-3. PubMed ID: 21236448
    [Abstract] [Full Text] [Related]

  • 18. Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens.
    Zisimopoulou P, Brenner T, Trakas N, Tzartos SJ.
    Autoimmun Rev; 2013 Jul 15; 12(9):924-30. PubMed ID: 23537507
    [Abstract] [Full Text] [Related]

  • 19. Biological implications of thymectomy for myasthenia gravis.
    Okumura M, Inoue M, Kadota Y, Hayashi A, Tokunaga T, Kusu T, Sawabata N, Shiono H.
    Surg Today; 2010 Jul 15; 40(2):102-7. PubMed ID: 20107947
    [Abstract] [Full Text] [Related]

  • 20. Acetylcholine receptor antibodies in myasthenia gravis.
    Kornfeld P, Nall J, Smith H, Mittag TW, Bender AN, Ambinder EP, Horowitz SH, Papatestas AE, Gross H, Genkins G.
    Muscle Nerve; 1981 Jul 15; 4(5):413-9. PubMed ID: 6974823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.